FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 360:1217-1225 March 19, 2009 Number 12 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text  Full Text Audio PowerPoint Slide Set CME Exam Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they exist. The article ends with the author's clinical recommendations.

A 39-year-old female executive has a several-month history of fatigue, headache, and memory lapse. Multiple specialists have performed evaluations, but no diagnosis has been established. During a period of feeling worse than usual, she called a friend, who arrived at the residence to find the woman semicomatose and called 911. The patient was given supplemental oxygen and transported to the emergency department, . . . [Full Text of this Article]

The Clinical Problem

Strategies and Evidence

Short-Term Management

Use of Hyperbaric Oxygen

Long-Term Management

Prevention

Areas of Uncertainty

Sequelae

Variability among Patients

Hyperbaric-Oxygen Therapy

Other Therapy

Guidelines

Conclusions and Recommendations

Source Information

From the Department of Hyperbaric Medicine, LDS Hospital; and the Department of Medicine, University of Utah School of Medicine — both in Salt Lake City; and the Department of Hyperbaric Medicine, Intermountain Medical Center, Murray, Utah.

An audio version of this article is available at NEJM.org.

Address reprint requests to Dr. Weaver at the Department of Hyperbaric Medicine, LDS Hospital, Eighth Ave. and C St., Salt Lake City, UT 84143, or at lindell.weaver@imail.org.

This article has been cited by other articles:

• Beckman, J. D., Belcher, J. D., Vineyard, J. V., Chen, C., Nguyen, J., Nwaneri, M. O., O'Sullivan, M. G., Gulbahce, E., Hebbel, R. P., Vercellotti, G. M. (2009). Inhaled carbon monoxide reduces leukocytosis in a murine model of sickle cell disease. Am. J. Physiol. Heart Circ. Physiol. 297: H1243-H1253 [Abstract] [Full Text]  
• Rosen, M. J. (2009). Other Pulmonary Disorders. ACCP Pulmonary Med Brd Rev 25: 285-294 [Full Text]